'One-Party Science'

J. Philippe Rushton certainly hits the nail on the head in his Commentary on "one-party science" (The Scientist, Oct. 3, 1994, page 13). His research on physical traits as related to race has caused him to be scorned as a pariah in the scientific community, without regard to his work's factual merits. But the "one-party system" goes far beyond Rushton. What if a life-sciences researcher stated that he doubted the hypothesis that evolution is responsible for the present diversity of biological

Written byJay Sonenthal
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

J. Philippe Rushton certainly hits the nail on the head in his Commentary on "one-party science" (The Scientist, Oct. 3, 1994, page 13). His research on physical traits as related to race has caused him to be scorned as a pariah in the scientific community, without regard to his work's factual merits. But the "one-party system" goes far beyond Rushton.

What if a life-sciences researcher stated that he doubted the hypothesis that evolution is responsible for the present diversity of biological species? This hypothesis is not even provable, since it addresses historical events. Surely intellectual freedom would demand he be allowed to express such doubts. Yet we all know he would not last very long in the scientific world, since he had blasphemed the party line.

Let's face it, scientists are a reactionary and conformist group of people, who are dedicated primarily to furthering their own careers at any cost.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies